Episode 859
TWiV 859: COVID-19 clinical update #99 with Dr. Daniel Griffin
January 29, 202237m 49s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #99, Daniel Griffin discusses Omicron disease severity, neurologic manifestations in children, testing outcomes during multiple infections, boosters improve VE and VD, booster efficacy for ED and UC encounters, vaccines induce cross-protective T cell memory, and indications for monoclonal antibody therapy.C
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Omicron disease severity (MMWR)
- Neurologic manifestations in children (Pediatric Neurol)
- Respiratory virus interference (Emerg Inf Dis)
- Hospitalization by vaccination status (CDC)
- Third vaccine dose VE (MMWR)
- Vaccination induces cross-reactive T cells (Cell)
- Limitations for monoclonal antibody use for Omicron (FDA)
- Internship at Parasites Without Borders (pdf) 42:40
- Letters read on TWiV 859
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]